Your browser doesn't support javascript.
loading
A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study.
Deng, Kexue; Wang, Lu; Liu, Yuchan; Li, Xin; Hou, Qiuyang; Cao, Mulan; Ng, Nathan Norton; Wang, Huan; Chen, Huanhuan; Yeom, Kristen W; Zhao, Mingfang; Wu, Ning; Gao, Peng; Shi, Jingyun; Liu, Zaiyi; Li, Weimin; Tian, Jie; Song, Jiangdian.
Affiliation
  • Deng K; Department of radiology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, USTC, Hefei, Anhui, China.
  • Wang L; Library of Shengjing Hospital of China Medical University, Shenyang, China.
  • Liu Y; School of Health Management, China Medical University, Shenyang, Liaoning, China.
  • Li X; Department of radiology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, USTC, Hefei, Anhui, China.
  • Hou Q; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Cao M; Department of radiology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, USTC, Hefei, Anhui, China.
  • Ng NN; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang H; Department of Radiology, School of Medicine Stanford University, Stanford CA 94305, United States.
  • Chen H; Radiation oncology department of thoracic cancer, Liaoning Cancer Hospital and Institute, Liaoning, China.
  • Yeom KW; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhao M; Department of Radiology, School of Medicine Stanford University, Stanford CA 94305, United States.
  • Wu N; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Gao P; PET-CT center, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Shi J; Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Liu Z; Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Li W; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Tian J; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Song J; Department of Respiratory and Critical Care Medicine, West China Hospital, Chengdu, Sichuan, China.
EClinicalMedicine ; 51: 101541, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35813093
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: EClinicalMedicine Year: 2022 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: EClinicalMedicine Year: 2022 Document type: Article Affiliation country: China Country of publication: United kingdom